BellaSeno's 3D-Printed Breast Scaffolds Show Promising Results in Clinical Trial
• BellaSeno's resorbable breast scaffolds, combined with fat grafting, demonstrate statistically significant superiority in breast volume retention compared to fat grafting alone, achieving 80% versus 60% volume sustenance.
• The clinical trial, involving 19 patients undergoing breast implant revision, reported no explantations, infections, necrosis, or typical silicone implant complications after 12-month follow-up in thirteen patients.
• Patient-reported outcomes indicate robust improvements in breast satisfaction, sexual well-being, and psychosocial well-being compared to pre-operative baselines, suggesting enhanced quality of life.
• BellaSeno's approach, utilizing 3D-printed polycaprolactone scaffolds, offers a potentially safer and more natural alternative to traditional silicone implants for breast augmentation and reconstruction.
© Copyright 2025. All Rights Reserved by MedPath